Welcome to light therapy Guide
Subject Medicine Light Therapy Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
Blue Light Therapy--a Form of Living Energy
from:The use of color therapy, such as the Blue Light Therapy, has been around a very long time, beginning with the healing temples of the ancient Greeks and Egyptians. Additionally, the ancient Chinese and Indians also used color in their healing practices that to this day are considered a major part of their alternative medicine practices, with the Blue Light Therapy part of the many colors used in the different healing methods.
Color therapy is based on how a person's organs are in relation to their chakras and meridians, resonating within individual frequencies. Blue Light Therapy is based on the color blue, a gentle color that is associated with communication, personal expression, and a person's ability to make correct decisions. By exposing the body to the blue color frequency, bringing about a more balanced state, the application of the Blue Light Therapy will increase a person's confidence when speaking, more of a mental relaxation, and increase a person's clarity in regard to their communication levels.
Studies on Blue Light Therapy have demonstrated that basically the use of light therapy resets the "biological clock" of the human body, with doses of 30 minutes to two hours each morning in front of a high-intensity fluorescent lamp an adequate time frame. One of the most highly successful treatments involve seasonal affective disorder (SAD), a condition where a person becomes depressed during shorter days during the fall and winter because of the reduced sunlight exposures that affect the body's internal clock.
In 2006, the Blue Light Therapy studies proved to be about 60% successful in the treatment of SAD. They showed that the body's biological clock responded in the most successful ways to a narrow band of wavelengths that were positioned in a range of 466 to 477 (nm). This color range was the blue of a clear blue sky. In another study, applying exposure to blue-LED light to Alzheimer's patients helped their body clocks adequately to sleep longer at night and also better than before the Blue Light Therapy treatment was given. But using the red light therapy in a similar Alzheimer study provided no successful results. And by applying yellow light therapy in combination with Blue Light Therapy, the Blue Light Therapy was cancelled out entirely.
The response to any form of light therapy usually will show results in about two to four days, but extensive disorders such as SAD or other forms of depression may take up to three weeks. If side effects occur, listed next, then decrease the time spent under the light:
• Eyestrain
• Visual disturbances
• Headaches
• Agitation
• Feelings of "weirdness"
• Sweating
• Nausea
Additionally, those individuals who have conditions such as sensitive skin or sensitive eyes need to discuss any form of light therapy with their therapist or doctor who are associated with the diagnosis and treatment before it is applied. If other forms of alternative medicine are used in conjunction with the light therapy, the therapist or doctor should also be notified.
Subject Medicine Light Therapy Specific links
Subject Medicine Light Therapy News
Dynatronics Announces Third Quarter Results
SALT LAKE CITY, May 15, 2012 /PRNewswire/ -- Dynatronics Corporation (DYNT) today announced results for its fiscal third quarter and nine months ended March 31, 2012.Sales for the fiscal third ...
Read more...POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 Migraine Treatment in 29 European Countries
POZEN Inc. , a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Desitin Arzneimittel GmbH, for the development and commercialization of MT 400 for the 27 countries of the European Union, as well as Switzerland and Norway.
Read more...VIVITROL® Data to be Presented at Upcoming American Psychiatric Association Annual Meeting
Alkermes plc today announced that data from several company-sponsored studies of naltrexone for extended-release injectable suspension are scheduled to be presented at the 2012 American Psychiatric Association Annual Meeting in Philadelphia, May 5-9, 2012.
Read more...Johnson & Johnson - Shareholder/Analyst Call
Johnson & Johnson (JNJ)April 26, 2012 10:00 am ET Executives William C. Weldon - Chairman of the Board and Chairman of Finance CommitteeDouglas K. Chia - Secretary and Assistant General CounselAlex Gorsky ...
Read more...Toward universal coverage – Taiwan’s experience
National health insurance I. Preface The World Health Organization (WHO) attaches great importance to the establishment of health care systems. Its 2010 World Health Report focused on universal health care, and the 2012 World
Read more...